The Technology Strategy Board and Medical Research Council has awarded a Knowledge Transfer Partnership (KTP) grant to Epistem and The University of Manchester to optimise, validate and commercialise new preclinical assays for wound repair.
Epistem hopes the partnership will enable expansion of its existing portfolio of wound healing models and provide a broad, innovative service range.
Dr Hardman said the partnership represents an opportunity to realise the potential of their work.
Epistem managing director Catherine Booth said Dr Hardman would provide their customers access to cutting edge preclinical models.